Medtronic to spin off diabetes business, form new company The separation is expected to be completed in 18 months.

Medical-device maker Medtronic MDT -0.13% plans to separate its diabetes business into a stand-alone company, the company said, in a move that hives off a division that had struggled but recently ...

Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps and other wearable devices, into a stand-alone company and forecast 2026 ...

Over the last five years, Medtronic's stock has shown a favorable one-day return following its earnings announcements in 53% of instances.

Halloween 1957: How a widespread blackout put Medtronic on the map with the invention of the portable pacemaker The outage rendered life-saving pacemakers useless, and triggered innovation.

As transformational as the pacemaker was, Martha believes a new Medtronic procedure, just approved by the FDA, will be even bigger.

Medtronic’s recent FDA-approved Aurora Extravascular Implantable Cardioverter Defibrillator (EV-ICD) is poised to revolutionise the cardiac device market. This device, which places leads outside ...

Medtronic said that the FDA approved its new spinal implant, which delivers a variable electrical pulse to interrupt pain signals before they reach the brain.

The Aurora EV-ICD is implanted below the left armpit and the lead is placed under the sternum through a minimally invasive procedure. "For Medtronic it's an important approval.

Medtronic has received FDA approval for the Aurora EV-ICD MRI SureScan for the treatment of tachicardia that can lead to sudden cardiac arrest. Read more here.